Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

Summary

The objectives are 1. to determine the immunological profile (CD4+, CD8+ cells, DTH) induced by immunization with HCV antigen peptide vaccine with polyarginine. 2. to document virological (HCV-RNA) and biochemical (ALT) responses following immunization with HCV antigen peptide vaccine with polyarginine. 3. to assess the safety of immunization with HCV antigen peptide vaccine with polyarginine.

Timeline

Start

2002-11

Primary completion

2004-05

Completion

2004-09

Drugs

Indications